P-243 Outcome and prognostic factors in surgical combined modality treatment of 131 stage IIIA-N2 non-small cell lung cancer (NSCLC) patients

Lung Cancer ◽  
2003 ◽  
Vol 41 ◽  
pp. S153
Author(s):  
Natalie Lorent ◽  
Johan Vansteenkiste ◽  
Paul De Leyn ◽  
Yolande Lievens ◽  
Kristiaan Nackaerts ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Prognostic Factors ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Combined Modality Treatment ◽  
Small Cell Lung ◽  
Stage Iiia ◽  
Combined Modality ◽  
Nsclc Patients

P-250 Combined modality treatment in stage IIIA/B non-small cell lung cancer

Lung Cancer ◽  
2003 ◽  
Vol 41 ◽  
pp. S155
Author(s):  
K.W. Maas ◽  
H.A. van Swieten ◽  
V. van Munnink ◽  
P. Hofman ◽  
F.M.N.H. Schramel
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Combined Modality Treatment ◽  
Small Cell Lung ◽  
Stage Iiia ◽  
Combined Modality

The effects of adjuvant therapy and prognostic factors in completely resected stage IIIa non-small cell lung cancer

1996 ◽  
Vol 43 (5) ◽  
pp. 709
Author(s):  
Se Haeng Cho ◽  
Kyung Young Chung ◽  
Joo Hang Kim ◽  
Byung Soo Kim ◽  
Joon Chang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Prognostic Factors ◽  
Adjuvant Therapy ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Stage Iiia ◽  
Resected Stage

Combined Modality Treatment of Locally Advanced Lung Cancer

1998 ◽  
Vol 84 (2) ◽  
pp. 259-269 ◽  
Author(s):  
Mauro G. Trovò ◽  
Marco Gigante ◽  
Emilio Minatel ◽  
Carlo Gobitti ◽  
Giovanni Franchin
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Locally Advanced ◽  
Small Cell ◽  
Advanced Lung Cancer ◽  
Combined Modality Treatment ◽  
Small Cell Lung ◽  
Combined Modality ◽  
Locally Advanced Lung Cancer

This paper describes the mechanisms of action of ionizing radiations combined with antineoplastic drugs. Some relevant drugs for the combined modality treatments of locally advanced lung cancer are reported. The meta-analyses including randomized trials comparing single agent (radiotherapy or chemotherapy) versus combined chemoterapy and radiotherapy in patients with unresectable non small cell lung cancer and limited small cell lung cancer are then reviewed. The clinical outcome in relation to different schedules of chemoradiotherapy (sequential, alternating and concurrent) is also focussed.

Potential molecular prognostic factors in non-small cell lung cancer (NSCLC) patients treated with gefitinib

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7089-7089
Author(s):  
C. Polowy ◽  
J. Coon ◽  
V. Villaflor ◽  
W. Leslie ◽  
I. Lukic ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Prognostic Factors ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Nsclc Patients

Potential clinical prognostic factors in non-small cell lung cancer (NSCLC) patients treated with gefitinib

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7088-7088
Author(s):  
V. M. Villaflor ◽  
C. R. Polowy ◽  
J. S. Coon ◽  
W. T. Leslie ◽  
I. Lukic ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Prognostic Factors ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Nsclc Patients
Sign in / Sign up

Export Citation Format

Share Document